Blueprint Medicines shares owned by Barclays
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $16M | 171k | 92.50 |
| 2024-06-30 | $26M | 238k | 107.79 |
| 2024-03-31 | $29M | 306k | 94.86 |
| 2023-12-31 | $31M | 336k | 92.23 |
| 2023-09-30 | $6.4M | 127k | 50.22 |
| 2023-06-30 | $6.6M | 104k | 63.20 |
| 2023-03-31 | $4.6M | 101k | 45.00 |
| 2022-12-31 | $5.4M | 124k | 43.81 |
| 2022-09-30 | $4.9M | 74k | 65.89 |
| 2022-06-30 | $1.3M | 25k | 50.48 |
| 2022-03-31 | $1.8M | 28k | 63.83 |
| 2021-12-31 | $7.8M | 73k | 107.11 |
| 2021-09-30 | $4.5M | 44k | 102.78 |
| 2021-06-30 | $950k | 11k | 87.92 |
| 2021-03-31 | $5.4M | 56k | 97.21 |
| 2020-12-31 | $3.7M | 33k | 112.13 |
| 2020-09-30 | $3.7M | 40k | 92.75 |
| 2020-06-30 | $9.5M | 122k | 78.00 |
| 2020-03-31 | $3.4M | 57k | 58.50 |
| 2019-12-31 | $8.7M | 109k | 80.11 |
| 2019-09-30 | $2.1M | 28k | 73.49 |
| 2019-06-30 | $7.0M | 74k | 94.33 |
| 2019-03-31 | $2.3M | 29k | 80.05 |
| 2018-12-31 | $181k | 3.3k | 54.27 |
| 2018-09-30 | $7.1M | 91k | 78.06 |
| 2018-06-30 | $1.3M | 20k | 63.57 |
| 2018-03-31 | $1.1M | 12k | 91.67 |
| 2017-12-31 | $698k | 9.2k | 75.43 |
| 2017-09-30 | $203k | 2.9k | 69.70 |
| 2017-06-30 | $128k | 2.5k | 50.60 |
| 2017-03-31 | $618k | 16k | 40.00 |
| 2016-12-31 | $82k | 2.9k | 28.21 |
| 2016-09-30 | $7.0k | 243 | 28.81 |
| 2016-06-30 | $7.0k | 330 | 21.21 |
| 2016-03-31 | $2.0k | 130 | 15.38 |
| 2015-12-31 | $12k | 482 | 25.00 |
| 2015-09-30 | $14k | 673 | 20.80 |
| 2015-06-30 | $21k | 804 | 25.60 |